Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Downgrades

Downgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Credit Suisse Downgrades Medical Properties Trust to Neutral, Lowers Price Target to $17

By Benzinga Newsdesk
July 14, 4:57 AM
Credit Suisse analyst Omotayo Okusanya downgrades Medical Properties Trust (NYSE:MPW) from Outperform to Neutral and lowers the price target from $23 to $17.

MPW

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Cantor Fitzgerald Downgrades ContraFect to Neutral, Lowers Price Target to $1

By Benzinga Newsdesk
July 14, 4:51 AM
Cantor Fitzgerald analyst Louise Chen downgrades ContraFect (NASDAQ:CFRX) from Overweight to Neutral and lowers the price target from $15 to $1.

CFRX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Piper Sandler Downgrades Unity Software to Neutral, Lowers Price Target to $34

By Benzinga Newsdesk
July 14, 4:34 AM
Piper Sandler analyst Brent Bracelin downgrades Unity Software (NYSE:U) from Overweight to Neutral and lowers the price target from $55 to $34.

U

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

RBC Capital Downgrades GrafTech – Read Why

By Akanksha Bakshi
July 13, 3:07 PM
RBC Capital analyst Arun Viswanathan downgraded GrafTech International Ltd (NYSE:EAF) to Sector Perform from Outperform and lowered the price target to $7 (an…

EAF

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

HC Wainwright Downgrades Humanigen On Disappointing COVID-19 Study – What’s Next

By Vandana Singh
July 13, 2:45 PM
HC Wainwright downgraded Humanigen Inc (NASDAQ:HGEN) to Neutral from Buy and removed the price target based on the removal of COVID-19…

HGEN

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Evercore ISI Group Downgrades Bath & Body Works to In-Line, Lowers Price Target to $28

By Benzinga Newsdesk
July 13, 9:45 AM
Evercore ISI Group analyst Omar Saad downgrades Bath & Body Works (NYSE:BBWI) from Outperform to In-Line and lowers the price target from $60 to $28.

BBWI

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Evercore ISI Group Downgrades Hanesbrands to In-Line, Lowers Price Target to $12

By Benzinga Newsdesk
July 13, 9:43 AM
Evercore ISI Group analyst Omar Saad downgrades Hanesbrands (NYSE:HBI) from Outperform to In-Line and lowers the price target from $18 to $12.

HBI

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Downgrades
  • Markets
  • News

Goldman Sachs Downgrades Parkland to Sell

By Benzinga Newsdesk
July 13, 8:57 AM
Goldman Sachs analyst Neil Mehta downgrades Parkland (TSX:PKI) from Neutral to Sell.

TSX:PKI

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Southern Copper to Sell, Lowers Price Target to $40

By Benzinga Newsdesk
July 13, 8:35 AM
Citigroup analyst Alexander Hacking downgrades Southern Copper (NYSE:SCCO) from Neutral to Sell and lowers the price target from $70 to $40.

SCCO

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades DigitalOcean Holdings to Sell, Lowers Price Target to $40

By Benzinga Newsdesk
July 13, 8:27 AM
Goldman Sachs analyst Gabriela Borges downgrades DigitalOcean Holdings (NYSE:DOCN) from Buy to Sell and lowers the price target from $54 to $40.

DOCN

Posts pagination

Previous 1 … 264 265 266 … 277 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service